(Q44486218)

English

Antiischemic and hemodynamic effects of an oral single dose of 150 mg of the phosphodiesterase inhibitor enoximone in patients with coronary artery disease—relation to plasma concentration

scientific article published on August 1, 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Antiischemic and hemodynamic effects of an oral single dose of 150 mg of the phosphodiesterase inhibitor enoximone in patients with coronary artery disease—relation to plasma concentration (English)

reason for preferred rank

most precise value

1 reference

10.1007/BF03029742

https://api.crossref.org/works/10.1007/BF03029742

5 December 2022

Antiischemic and hemodynamic effects of an oral single dose of 150 mg of the phosphodiesterase inhibitor enoximone in patients with coronary artery disease--relation to plasma concentration (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832289

5 December 2022

Cardiology and cardiovascular medicine

1 reference

10.1007/BF03029742

https://api.crossref.org/works/10.1007/BF03029742

5 December 2022

1 reference

10.1007/BF03029742

https://api.crossref.org/works/10.1007/BF03029742

5 December 2022

author name string

V. Mitrovic

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832289

5 December 2022

O. Petrovic

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832289

5 December 2022

H. Bahavar

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832289

5 December 2022

J. Neuzner

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832289

5 December 2022

H. A. Dieterich

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832289

5 December 2022

M. Schlepper

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832289

5 December 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1832289

5 December 2022

publication date

1 August 1991

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

full work available at URL

http://link.springer.com/content/pdf/10.1007/BF03029742.pdf

Portable Document Format

1 reference

10.1007/BF03029742

https://api.crossref.org/works/10.1007/BF03029742

5 December 2022

http://link.springer.com/article/10.1007/BF03029742/fulltext.html

1 reference

10.1007/BF03029742

https://api.crossref.org/works/10.1007/BF03029742

5 December 2022

http://link.springer.com/content/pdf/10.1007/BF03029742

1 reference

10.1007/BF03029742

https://api.crossref.org/works/10.1007/BF03029742

5 December 2022

Cardiovascular Drugs and Therapy

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

689-695

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

A dose-response study of intravenous enoximone in congestive heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/1832289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of phosphodiesterase inhibition on myocardial oxygen consumption and coronary blood flow

1 reference

https://pubmed.ncbi.nlm.nih.gov/1832289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term treatment with oral enoximone for chronic congestive heart failure: the European experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/1832289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous use of enoximone.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1832289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potential mechanisms of improved left ventricular function with enoximone in severe congestive heart failure.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1832289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overview of cardiovascular physiologic and pharmacologic aspects of selective phosphodiesterase peak III inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/1832289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacology of enoximone

1 reference

https://pubmed.ncbi.nlm.nih.gov/1832289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inotropic effect of enoximone in patients with severe heart failure: demonstration by left ventricular end-systolic pressure-volume analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/1832289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute hemodynamic response to low dose enoximone (MDL 17,043): an oral dose-range study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1832289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term oral enoximone therapy in chronic cardiac failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/1832289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biotransformation and pharmacokinetic overview of enoximone and its sulfoxide metabolite

1 reference

https://pubmed.ncbi.nlm.nih.gov/1832289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A preliminary report of the effects of orally administered enoximone on regional hemodynamics in congestive heart failure.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1832289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/1832289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Positive inotropic and vasodilator effects of MDL 17,043 in patients with reduced left ventricular performance

1 reference

https://pubmed.ncbi.nlm.nih.gov/1832289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical aspects of inhibition of cardiovascular low (Km) cyclic adenosine monophosphate phosphodiesterase

1 reference

https://pubmed.ncbi.nlm.nih.gov/1832289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind dose response comparison of oral enoximone and placebo for congestive heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/1832289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hemodynamic, antiischemic, and neurohumoral effects of enoximone in patients with coronary artery disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1832289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous and oral MDL 17043 (A new inotrope-vasodilator agent) in congestive heart failure: Hemodynamic and clinical evaluation in 38 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/1832289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The acute hemodynamic effects of a new agent, MDL 17,043, in the treatment of congestive heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/1832289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alterations in left ventricular function, coronary hemodynamics and myocardial catecholamine balance with MDL 17043, a new inotropic vasodilator agent, in patients with severe heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/1832289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Journal of applied cardiology

13

4

31

author name string

J Thormann

publication date

1989

1 reference

10.1007/BF03029742

https://api.crossref.org/works/10.1007/BF03029742

5 December 2022

Identifiers

10.1007/BF03029742

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44486218&oldid=1784799481"